Literature DB >> 27681797

Cancer: BMI1 inhibition reverses lung cancer.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27681797     DOI： 10.1038/nrd.2016.197

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.

Authors:  Kol Jia Yong; Daniela S Basseres; Robert S Welner; Wen Cai Zhang; Henry Yang; Benedict Yan; Meritxell Alberich-Jorda; Junyan Zhang; Lorena Lobo de Figueiredo-Pontes; Chiara Battelli; Christopher J Hetherington; Min Ye; Hong Zhang; Giorgia Maroni; Karen O'Brien; Maria Cristina Magli; Alain C Borczuk; Lyuba Varticovski; Olivier Kocher; Pu Zhang; Young-Choon Moon; Nadiya Sydorenko; Liangxian Cao; Thomas W Davis; Bhavin M Thakkar; Ross A Soo; Atsushi Iwama; Bing Lim; Balazs Halmos; Donna Neuberg; Daniel G Tenen; Elena Levantini
Journal:  Sci Transl Med       Date:  2016-08-03       Impact factor: 17.956
  1 in total
  1 in total

1.  Mitotic polarization of transcription factors during asymmetric division establishes fate of forming cancer cells.

Authors:  Yongqing Liu; Laura Siles; Xiaoqin Lu; Kevin C Dean; Miriam Cuatrecasas; Antonio Postigo; Douglas C Dean
Journal:  Nat Commun       Date:  2018-06-21       Impact factor: 14.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.